Kun Lieh Yang
Directeur/Membre du Conseil chez FORMOSAN UNION CHEMICAL CORP.
Profil
Kun Lie Yang currently works at Hong Jing Resources Co., Ltd., as Chairman from 2017, Formosan Union Chemical Corp., as Director from 2002, Formosa Biomedical Technology Corp., as General Manager & Director, and United BioPharma, Inc., as Director.
Postes actifs de Kun Lieh Yang
| Sociétés | Poste | Début |
|---|---|---|
| FORMOSAN UNION CHEMICAL CORP. | Directeur/Membre du Conseil | 01/06/2002 |
| UNITED BIOPHARMA INC | Directeur/Membre du Conseil | - |
Hong Jing Resources Co., Ltd.
 Hong Jing Resources Co., Ltd. Financial ConglomeratesFinance Hong Jing Resources Co., Ltd. engages in the operation of waste treatment enterprises. Its business activities include waste removal, environmental testing services, waste cleaning, hardware wholesale, non-ferrous metal, and international trade industries. The company was founded on January 20, 2006 and is headquartered in Kaohsiung, Taiwan. | Président | 04/07/2017 |
Formosa Biomedical Technology Corp.
 Formosa Biomedical Technology Corp. Household/Personal CareConsumer Non-Durables Formosa Biomedical Technology Corp. engages in developing and manufacturing high-tech, quality, safe and healthy products by integrating its three major resources of Formosa Group in manufacturing, academic studies and clinical research & services. The company was founded on November 10, 2009 and is headquartered in Taipei, China. | Directeur Général | 06/03/2012 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| FORMOSAN UNION CHEMICAL CORP. | Process Industries |
| Entreprise privées | 3 |
|---|---|
United BioPharma, Inc.
 United BioPharma, Inc. Pharmaceuticals: MajorHealth Technology United BioPharma, Inc. engages in the development, manufacture, and sale of monoclonal antibody drug. The company's business activities include the manufacture and sale of western drugs. Its products include trastumab, adalimumab, bevacizumab, rituximab, and omalizumab. The company was founded by Chang Yi Wang on September 30, 2013 and is headquartered in Hsinchu, Taiwan. | Health Technology |
Hong Jing Resources Co., Ltd.
Hong Jing Resources Co., Ltd. Financial ConglomeratesFinance Hong Jing Resources Co., Ltd. engages in the operation of waste treatment enterprises. Its business activities include waste removal, environmental testing services, waste cleaning, hardware wholesale, non-ferrous metal, and international trade industries. The company was founded on January 20, 2006 and is headquartered in Kaohsiung, Taiwan. | Finance |
Formosa Biomedical Technology Corp.
Formosa Biomedical Technology Corp. Household/Personal CareConsumer Non-Durables Formosa Biomedical Technology Corp. engages in developing and manufacturing high-tech, quality, safe and healthy products by integrating its three major resources of Formosa Group in manufacturing, academic studies and clinical research & services. The company was founded on November 10, 2009 and is headquartered in Taipei, China. | Consumer Non-Durables |